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Knockdown of Filaggrin in a Three-Dimensional
Reconstructed Human Epidermis Impairs Keratinocyte
Differentiation
Vale´rie Pendaries1,2,3, Jeremy Malaisse4, Laurence Pellerin1,2,3, Marina Le Lamer1,2,3, Rachida Nachat1,2,3,8,
Sanja Kezic5, Anne-Marie Schmitt6, Carle Paul1,2,3,7, Yves Poumay4, Guy Serre1,2,3 and Michel Simon1,2,3
Atopic dermatitis is a chronic inflammatory skin disorder characterized by defects in the epidermal barrier and
keratinocyte differentiation. The expression of filaggrin, a protein thought to have a major role in the function of
the epidermis, is downregulated. However, the impact of this deficiency on keratinocytes is not really known.
This was investigated using lentivirus-mediated small-hairpin RNA interference in a three-dimensional recon-
structed human epidermis (RHE) model, in the absence of other cell types than keratinocytes. Similar to what is
known for atopic skin, the experimental filaggrin downregulation resulted in hypogranulosis, a disturbed
corneocyte intracellular matrix, reduced amounts of natural moisturizing factor components, increased
permeability and UV-B sensitivity of the RHE, and impaired keratinocyte differentiation at the messenger RNA
and protein levels. In particular, the amounts of two filaggrin-related proteins and one protease involved in the
degradation of filaggrin, bleomycin hydrolase, were lower. In addition, caspase-14 activation was reduced. These
results demonstrate the importance of filaggrin for the stratum corneum properties/functions. They indicate that
filaggrin downregulation in the epidermis of atopic patients, either acquired or innate, may be directly
responsible for some of the disease-related alterations in the epidermal differentiation program and epidermal
barrier function.
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INTRODUCTION
Atopic dermatitis (AD; OMIM #603165) is one of the most
common chronic inflammatory skin diseases, affecting 15–
25% of children and 3% of adults in industrialized countries
(Odhiambo et al., 2009; Bieber, 2012). The pathophysiology
of AD is complex and involves numerous genetic and
environmental factors. Clinically, AD is characterized by
erythematous skin lesions, pruritis, increased transepidermal
water loss, and a marked mononuclear cell infiltrate in the
dermis. It was long thought that the AD primary defect resided
in the immune system, leading to excessive inflammation and
a secondary local epidermal barrier disruption. However,
some recent studies have suggested that permeability barrier
abnormality in AD is not merely a consequence but rather the
‘‘driver’’ of the disease activity, allowing antigen penetration
and percutaneous sensitization (Cork et al., 2006; Oyoshi
et al., 2009; Novak and Simon, 2011; Bieber, 2012; Kezic
et al., 2014). Loss-of-function mutations in the gene-encoding
filaggrin (FLG) are the strongest and most widely replicated
risk factors for the disease (Kezic et al., 2014). Meta-analyses
of genetic studies involving many thousands of patients have
demonstrated this association, with an overall odds ratio for
AD ranging from 3.12 to 4.78 (Baurecht et al., 2007;
Rodriguez et al., 2009). Many clinical features of atopic skin
have been associated with FLG mutations: a decrease in the
levels of free amino acids in the stratum corneum (SC) (Kezic
et al., 2008), an increase in transepidermal water loss and SC
pH (Kezic et al., 2008; Jungersted et al., 2010; Winge et al.,
2011), dryness (Winge et al., 2011), and abnormal bacterial
colonization (Boguniewicz and Leung, 2011).
Filaggrin is produced by granular keratinocytes as a large
precursor called profilaggrin, which consists of 10–12 filaggrin
repeats flanked by single N- and C-terminal domains. Profi-
laggrin is the major component of the keratohyalin granules.
At the granular-to-cornified cell transition, profilaggrin is
rapidly dephosphorylated and cleaved to generate basic
filaggrin monomers and terminal domains (Dale et al., 1985;
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Brown and McLean, 2011). The N terminus is translocated
into the nucleus where it may be involved in nuclear
breakdown (Ishida-Yamamoto et al., 1998; Pearton et al.,
2002). As for the filaggrin monomers, they associate with
keratin filaments and are suspected of inducing the formation
of the corneocyte fibrous matrix (Steinert et al., 1981). In the
cornified cells, after deimination by peptidylargine deimi-
nases, filaggrin is degraded into free amino acids by some
proteases, including caspase-14, bleomycin hydrolase, and
calpain 1 (Scott et al., 1982; Chavanas et al., 2006; Baurecht
et al., 2007; Denecker et al., 2008; Brown and McLean,
2011). These amino acids are thought to be critical for skin
photoprotection and for the acidification and hydration of the
SC (Scott et al., 1982; Rawlings and Harding, 2004; Elias and
Steinhoff, 2008; Brown and McLean, 2011).
To prove the importance of filaggrin and analyze its
functions, filaggrin-null mice and filaggrin knockdown in
organotypic human skin models have been studied. However,
conflicting results have been obtained. In mice, complete
filaggrin deficiency leads to dry scaly skin, SC fragility,
abnormal keratin aggregation, decreased amino acid levels
in the SC, altered epidermal barrier integrity, and enhanced
percutaneous sensitization, but normal SC water content,
conductance, and pH (Kawasaki et al., 2012). In vitro
knockdown of human filaggrin with small interfering RNA
(Mildner et al., 2010) or microRNA (Aho et al., 2012) in two
living-skin equivalent models has led to different results. In
2010, Mildner et al. (Mildner et al., 2010) reported impaired
lamellar body formation, reduced urocanic acid content in the
SC, increased penetration through the SC, and increased
sensitivity to UV-B-induced apoptosis, but normal keratin
solubility, keratinocyte proliferation and differentiation, and
SC lipid composition. In 2012, a second study showed
increased thickness of the epidermis with an increase in
keratin 16 expression and activation of caspase-14 (Aho
et al., 2012). Finally, small interfering RNA knockdown of
filaggrin in HaCaT cells grown at the air–liquid interface
showed reduced expression of loricrin, E-cadherin, and
occludin (Yoneda et al., 2012).
To better understand the effect of filaggrin deficiency on
keratinocytes in a fibroblast- and immunological cell-free
context, we knocked down its expression with small-hairpin
RNA (shRNA) technology in reconstructed human epidermis
(RHE) on a polycarbonate filter. We particularly focused on
epidermal differentiation, SC properties, and permeability
barrier.
RESULTS
Filaggrin deficiency in RHE leads to a thinner epidermis, loss of
keratohyalin granules, and impaired SC formation
Filaggrin expression knockdown was achieved using RNA
interference in normal human primary keratinocytes, which
were secondarily used to obtain RHE as previously described
(Frankart et al., 2012). The experiments were performed with
two shRNAs targeting filaggrin (shFLGa and shFLGb) and
keratinocytes obtained from three different donors. Similar
levels of filaggrin expression were observed in RHE produced
with keratinocytes from any of the donors (Supplementary
Figure S1 online). The two shRNAs were used separately, with
identical results (for comparison, some results obtained with
shFLGb are shown in Supplementary Figure S2 online).
After 10 days of culture at the air–liquid interface, fully
differentiated epidermis was obtained. As previously reported
(Frankart et al., 2012), proper expression of keratins and
differentiation markers was achieved and the SC was
functionally competent. The RHE produced with keratino-
cytes transduced with either a control shRNA (shc-RHE) or
shFLGa (shFLG-RHE) was analyzed by quantitative real-time
reverse-transcriptase–PCR (RT-qPCR), and immunodetected
with AHF3, a monoclonal antibody specific for filaggrin and
profilaggrin, using western blotting and indirect immuno-
fluorescence (Figure 1). In shFLG-RHE, filaggrin mRNA and
protein (both profilaggrin and filaggrin monomers) amounts
were decreased by 92% and 90%, respectively, compared
with shc-RHE (Figure 1a and b). Immunofluorescence labeling
of RHE sections showed the expression of profilaggrin in the
granular layers of shc-RHE, and a marked reduction of staining
in shFLG-RHE (Figure 1c).
Morphologically, shc-RHE was similar to normal human
epidermis, as shown by hematoxylin–eosin staining. In con-
trast, shFLG-RHE appeared thinner with a reduced number of
keratinocyte layers and reduced SC thickness, and a marked
reduction in keratohyalin granules (Figure 2a and Supple-
mentary Figure S3a and b online). Transmission electron
microscopy analysis (Figure 2b) of shc-RHE showed keratino-
cyte organization and structures similar to those observed
in normal human skin, including corneodesmosomes,
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Figure 1. Expression of filaggrin is highly reduced in RHE produced with
shFLG keratinocytes. (a–c) Fully differentiated shc- and shFLG-reconstructed
human epidermis (RHE) were analyzed by quantitative real-time reverse-
transcriptase–PCR (a), and by both western blotting (b) and
immunofluorescence (c; in red) performed with an AHF3 antibody.
Immunodetected profilaggrin and filaggrin monomers were quantified and
normalized to GAPDH levels. Error bars represent the SD calculated from three
experiments performed with keratinocytes from three different donors, each in
triplicate. The polycarbonate filter–epidermal junction is indicated by thin
lines. Bars ¼ 50mm.
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desmosomes, keratohyalin granules, and lamellar bodies. The
ultrastructural examination of shFLG-RHE confirmed the
reduction in keratohyalin granules (Supplementary Figure
S3c online) and SC thickness. In addition, corneocytes
displayed an unusually low electron density of their matrix,
and corneodesmosomes were not observed. The analysis also
indicated an apparent dilation of the extracellular spaces in
the upper living keratinocyte layers. However, the desmo-
somes and the distribution of desmosomal proteins and
E-cadherin appeared normal (Supplementary Figure S4
online). In addition, the keratinocyte proliferation before
epidermal reconstruction was not modified by the down-
regulation of filaggrin (Supplementary Figure S5a online),
active caspase-3 was not detected (data not shown and
Figure 3c), and cellular viability, as tested using a 3(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay, was not altered (Supplementary Figure S5d online) in
shFLG-RHE. However, on day 10, a slight but statistically
significant reduction in Ki67 staining was observed
(Supplementary Figure S5b and c online). This suggested that
the reduced thickness was due to keratinocyte altered differ-
entiation and reduced proliferation.
SC functional properties are disturbed in filaggrin-deficient
RHE
To investigate the effect of filaggrin knockdown on SC
permeability, we used the Lucifer yellow assay (Mildner
et al., 2010). The hydrophilic fluorescent dye was applied to
the shc- and shFLG-RHE external surface for 6 hours on day
10. The green dye was retained in the SC of the control RHE
(Figure 3a, left panel) but passed through the filaggrin-deficient
RHE and markedly stained the polycarbonate filter (Figure 3a,
right panel).
Amino acids derived from filaggrin degradation are thought
to partly regulate the pH in the SC. Therefore, we analyzed the
pH of the external surface of the RHE. Filaggrin inhibition,
however, was not shown to induce any noticeable pH
modifications (from 6.38±0.25 to 6.49±0.15; P¼0.21;
Supplementary Figure S6 online). To know whether filaggrin
reduction impacted the natural moisturizing factor, we mea-
sured the urocanic acid and pyrrolidone carboxylic acid
contents of the RHE (Dapic et al., 2013). HPLC analysis of
RHE lysates revealed statistically significant decreases of
urocanic (31%; from 5.90 to 4. 10 mmoles ml1) and pyrro-
lidone carboxylic (18%; from 45.83 to 37.80 mmoles ml1)
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Figure 2. Filaggrin deficiency leads to altered epidermal morphology. (a) Sections of paraffin-embedded shc- and shFLG-reconstructed human epidermis (RHE)
were stained with hematoxylin and eosin. One representative experiment of three is shown. Bars ¼ 20mm. (b) Normal epidermis (NE), shc-, and shFLG-RHE were
analyzed by electron microscopy, as described in Supplementary Materials and Methods online. Corneodesmosomes (white arrows), desmosomes (black arrows),
and keratohyalin granules (arrowheads) were observed. The stratum corneum (SC) and granulosum (G) are indicated. Scale bars are shown.
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acids in filaggrin knockdown RHE as compared with the
control samples (Figure 3b).
Urocanic acid is suspected to protect skin against UV-B
radiation (Barresi et al., 2011). We therefore irradiated shc-
and shFLG-RHE and detected active caspase-3 as a marker of
apoptosis induction (Figure 3c). Knockdown of filaggrin
resulted in an increase in caspase-3 activation, suggesting
increased UV sensitivity.
Filaggrin knockdown in RHE affects the epidermal differentiation
program
To study keratinocyte differentiation in RHE, we explored the
expression of a panel of proteins differentially expressed in the
various layers of the epidermis by western blotting and
quantification of the detected bands (Figure 4a and b). We
considered a change in protein immunodetection by a
factor of 1.5 as significant. Compared with control RHE, the
detection of the following proteins was decreased in
filaggrin-deficient RHE: filaggrin-2, hornerin, keratin (K) 10,
loricrin, caspase-14 (both the precursor and active forms),
and bleomycin hydrolase. In contrast, the detection of
corneodesmosin and claudin 1 increased. The expression of
desmoglein 1/2, desmocollin 1, involucrin, K14, E-cadherin,
and calpain 1 was not modified. Immunofluorescence labeling
confirmed the decrease in filaggrin-2, hornerin, caspase-14,
and bleomycin hydrolase detection (Figure 4c). Interestingly,
the distribution of corneodesmosin was shown to be altered
with little pericellular labeling observed (Supplementary
Figure S4b online), in agreement with the absence of
corneodesmosomes.
To determine whether the modifications of protein expres-
sion observed in shFLG-RHE were due to changes in the
corresponding mRNA levels, a quantitative real-time PCR
analysis was performed (Figure 4d). In comparison with
control RHE samples, mRNA levels of filaggrin-2, loricrin,
caspase-14, and bleomycin hydrolase were reduced in
filaggrin-deficient RHE, whereas the corneodesmosin
mRNA level was increased. The levels of mRNAs encoding
hornerin, K10, K14, desmoglein 1, desmocollin 1, involucrin,
claudin 1, E-cadherin, and calpain 1 were modified only
slightly or not at all.
Procaspase-14 activation is reduced in both shFLG-RHE and
atopic skin
In the shFLG-RHE, in addition to the downregulation of
caspase-14, a reduction in the processing of the proform to
the active form of the protease was observed (mean factor of
55.6±4.4; n¼ 4). To know whether this was also the case in
AD, total protein extracts of normal epidermis and of the
epidermis from both lesional and non-lesional skin of AD
patients were analyzed by western blotting. Patients and
controls without any of the four FLG mutations most prevalent
in the European population (R501X, 2282del4, S3247X, and
R2447X) were selected. The amounts of procaspase-14 and
caspase-14 large subunit detected and the procaspase-14/
caspase-14 ratio were then computed. Large interindividual
variations were observed in the amounts of both the proform
and the activated form. The amounts of procaspase-14 were
increased in the lesional skin samples, as compared with non-
lesional and control skin (P¼ 0.00987 and P¼ 0.00094,
respectively). The amounts of caspase-14 seemed to be reduced
in patients (both in non-lesional and lesional skin samples), but
the decreases were not statistically significant (Supplementary
Figure S7 online). However, as observed in the RHE, the
activation of procaspase-14 was reduced in the patients
(Supplementary Figure S8 online). The mean ratio of 5.06 in
controls was shown to increase to 15.47 in lesional and to
11.82 in non-lesional atopic skin samples. We did not find any
correlation between the reduced activation of caspase-14 and
the amounts of filaggrin quantified in the epidermal extracts
using western blotting (data not shown). This is not surprising as
caspase-14 seems to proteolyze filaggrin fragments, already
processed by another protease, rather than filaggrin monomers,
at least in the mouse (Denecker et al., 2008).
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Figure 3. The stratum corneum properties of filaggrin-deficient RHE are impaired. (a) A solution of Lucifer yellow was applied onto the stratum corneum of the
shc- and shFLG-reconstructed human epidermis (RHE) . After 6 hours, penetration of the dye was investigated using sections of paraffin-embedded tissue observed
under a fluorescence microscope. The stratum corneum surface (thick line) and the polycarbonate filter (thin lines) are indicated. Bars ¼ 20mm. (b) Urocanic acid
(t-UCA) and pyrrolidone carboxylic acid (PCA) amounts were quantified using HPLC in lysates of shc-RHE (n¼ 8) and shFLG-RHE (n¼9). *Po0.05; **Po0.001.
Means and SE are indicated. (c) Shc- and shFLG-RHE were irradiated with UV-B (150 mJ cm-2), and the active caspase-3 was detected using indirect
immunofluorescence (in red). DNA was labeled with 40,60-diamidino-2-phenylindole (in blue).
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DISCUSSION
Nonsense mutations in the gene-encoding filaggrin are
responsible for ichthyosis vulgaris and are frequently asso-
ciated with AD (Baurecht et al., 2007; Rodriguez et al., 2009;
Brown and McLean, 2011). Moreover, the expression of
filaggrin and other major constituents of the SC is decreased
in adult AD patients, both in lesional and non-lesional skin,
irrespectively of their FLG genotype (Pellerin et al., 2013).
However, the real impact of filaggrin deficiency on the
epidermal barrier is not completely known. To answer this
question we used RHE as a 3D model produced with
keratinocytes only, without any other cell types. We report
here that filaggrin knockdown by RNA interference
technology in RHE extensively alters keratinocyte
differentiation, SC integrity, and SC function. In particular, a
very small number of keratohyalin granules, reduced thickness
of the epidermis, including a very thin SC, apparent
spongiosis, a disturbed corneocyte intracellular matrix,
increased outside-in SC permeability, decreased amounts of
urocanic and pyrrolidone carboxylic acids, increased UV-B
sensitivity, and an altered differentiation program, both at the
mRNA and protein levels, were observed. This demonstrates
the importance of filaggrin in epidermis homeostasis.
One particularly puzzling modification is the thickness of
the RHE. The number of nucleated keratinocyte layers as well
as the cellular proliferation rate decreased, but less markedly.
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Figure 4. Filaggrin knockdown alters keratinocyte differentiation. (a–d) Expression of proteins in shc- and shFLG-reconstructed human epidermis (RHE) was either
analyzed by western blotting (a) and quantified (b) or investigated by immunofluorescence staining (c) and quantitative real-time reverse-transcriptase–PCR (d).
FLG, filaggrin; HRNR, hornerin; K, keratin; LOR, loricrin; DSG, desmoglein; DSC, desmocollin; CASP14, caspase-14 (both precursor (*) and active (**) forms);
BLMH, bleomycin hydrolase; CDSN, corneodesmosin; CLDN, claudin; IVL, involucrin; CDH1, E-cadherin; CAPN, calpain; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase. Error bars represent the SD calculated as indicated in the legend of Figure 1. The polycarbonate filter– and dermo-epidermal junctions are
indicated by dashed lines. Scale bars ¼ 20mm. **Po0.01; ***Po0.001.
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This difference is therefore probably because of defects in
keratinocyte differentiation and proliferation.
Mainly on the basis of in vitro or indirect experiments,
filaggrin is thought to be essential for the SC, both as a
structural protein and as a major source of SC free amino
acids, which are highly hygroscopic, absorb part of the UV
radiation, and control the SC surface pH (Scott et al., 1982;
Rawlings and Harding, 2004; Elias and Steinhoff, 2008; Brown
and McLean, 2011). It has been suggested that filaggrin
promotes the aggregation of intermediate filaments to form
the corneocyte intracellular matrix, and is then degraded
within the SC into free amino acids, including large amounts
of histidine and glutamine. Histidine and glutamine are further
metabolized to urocanic acid and pyrrolidone 5-carboxylic
acid, respectively. Urocanic acid was suggested to be
involved in skin photoprotection. In support of these possi-
bilities, we have shown that filaggrin knockdown in RHE
induces a reduction in pyrrolidone carboxylic and urocanic
acids, an increased UV-B-induced apoptosis of keratinocyte,
and a disorganized fibrous matrix of corneocytes. The same
was observed in recently characterized filaggrin knockout
mice (Kawasaki et al., 2012). In addition, filaggrin-deficient
epidermis, in both shFLG-RHE and filaggrin knockout mice
(Table 1), shows increased penetration of foreign material
through the SC—by means of Lucifer yellow in this study and
liposome-encapsulated calcein in the mouse study—clearly
demonstrating the importance of the protein. However, as
observed in the filaggrin-null mice, inhibition of filaggrin
expression in RHE does not affect the SC surface pH. This is
consistent with a previously published report that filaggrin is
not essential for SC acidification (Fluhr et al., 2010). This
unexpected result, also observed in filaggrin knockdown
three-dimensional skin, has been tentatively explained by
compensatory upregulations of the NHE-1 sodium/hydrogen
antiporter and sPLA2 secretory phospholipase (Vavrova et al.,
2013).
We observed that filaggrin knockdown in RHE significantly
influenced keratinocyte differentiation, at both the protein and
mRNA levels. Detection of filaggrin-2 and hornerin, two S100-
fused type proteins, was decreased. It should be noted that
expression of the three proteins appears to be co-regulated
in vivo and in vitro (Pellerin et al., 2013). Caspase-14 and
bleomycin hydrolase, two proteases involved in filaggrin
degradation, were downregulated, whereas calpain 1
expression was not affected. Two components of cornified
cell envelopes were decreased, namely loricrin and the
above-mentioned hornerin, suggesting defects in these
structures. This is in agreement with the finding that the
expression of loricrin is also markedly inhibited in RHE
produced with HaCaT cells treated by a small interfering
RNA-targeting filaggrin (Yoneda et al., 2012). Finally, in the
shFLG RHE, two proteins of cellular junctions, corneodes-
mosin and claudin 1, are upregulated. These are components
of desmosomes/corneodesmosomes and tight junctions,
respectively. This suggests the existence of a compensatory
mechanism to try to overcome a permeability barrier defect
and prevent a more severe phenotype. A similar mechanism
has been reported in mice lacking key SC proteins and having
a disturbed epidermal barrier (Koch et al., 2000). However,
probably because of impaired differentiation, corneodesmo-
somes were not formed, even though desmosomes appeared
normal, and corneodesmosin localization was altered. This
may be due to abnormalities in the mechanisms of
keratinocyte secretion, lamellar body defects having been
described in filaggrin knockdown organotypic skin (Mildner
et al., 2010).
Table 1. Knockdown of filaggrin in reconstructed human epidermis (shFLG RHE) recapitulated some defects
observed in the epidermis of Flg knockout mice and of IV and AD patients
shFLG RHE Flg knockout mice1 IV2 AD
Hypogranulosis þ þ þ þ
Reduced stratum corneum thickness þ þ /  þ /
Enlargement of extracellular spaces þ   þ
Disturbed corneocyte matrix þ þ þ þ
Increased SC permeability þ þ þ þ
Reduced amounts of urocanic and pyroxylic acids þ þ þ þ
Reduced expression of filaggrin-2 and hornerin þ Unknown Unknown þ
Reduced activation of caspase-14 þ Unknown Unknown þ
Reduced expression of bleomycin hydrolase þ Unknown Unknown þ
Reduced expression of loricrin þ   þ
Abnormal expression of tight junction proteins þ Unknown þ þ
Abnormal corneodesmosome density þ Unknown þ Unknown
Increased pH   þ þ
Abbreviations: AD, atopic dermatitis; Flg, filaggrin gene; IV, ichthyosis vulgaris; RHE, reconstructed human epidermis; SC, stratum corneum.
1(Kawasaki et al., 2012).
2(Gruber et al., 2011).
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In contrast to our observations, Mildner et al. (2010) have
reported an impairment of the SC diffusion barrier function but
normal keratinocyte differentiation and SC morphology when
filaggrin is knocked down in human skin equivalents. This
difference may be explained by the presence of normal
fibroblasts in the collagen matrix they used in Mildner’s
model. The fibroblasts could partially correct the abnormal
keratinocyte phenotype. In models of skin reconstructed
in vitro and consisting of keratinocytes growing on a
scaffold-based dermal equivalent, fibroblasts located in the
dermal matrix have already been reported to improve
keratinocyte differentiation and sustain epidermal viability
(Boehnke et al., 2007). In agreement with our hypothesis,
a more recent study using three-dimensional organotypic
skin cultures has shown that healthy fibroblasts in the
collagen matrix are able to stimulate the expression of
filaggrin in atopic keratinocytes (Berroth et al., 2013).
This effect could be due to Jun N-terminal kinase-dependent
and soluble factors produced by fibroblasts (Schumacher
et al., 2014). Several experiments in vivo and in vitro have
also highlighted the leukemia inhibitory factor, a member
of the IL-6 family of cytokines whose expression is reduced
in atopic skin, as being involved in this process (Berroth et al.,
2013).
Many features induced by filaggrin deficiency in RHE have
been reported in AD patients (Table 1). These include, in
particular, broad defects in epidermal cornification: reduced
amount of natural moisturizing factor, altered SC permeability,
spongiosis, hypogranulosis, decreased compaction of keratin
filaments (Sugiura et al., 2005; Guttman-Yassky et al., 2009;
Suarez-Farinas et al., 2011), downregulation of genes
encoding loricrin, bleomycin hydrolase, caspase-14, and
filaggrin-2 (Sugiura et al., 2005; Guttman-Yassky et al.,
2009; Suarez-Farinas et al., 2011), and decreased detection
of filaggrin-2, hornerin, caspase-14, bleomycin hydrolase, and
loricrin (Broccardo et al., 2011; Kamata et al., 2011; Suarez-
Farinas et al., 2011; Pellerin et al., 2013). In addition, in
shFLG-RHE we observed a reduction in the conversion rate of
procaspase-14 to the active form of the protease. A similar
trend has been suggested recently in the epidermis of AD
patients, from the study of tape stripping extracts by ELISA
(Yamamoto et al., 2011). This prompted us to analyze
epidermal extracts of control skin and of both non-lesional
and lesional skin of AD patients. Our present data clearly
indicate some defect of the caspase-14 activation pathway in
AD skin. As caspase-14 deficient mice have shown higher
transepidermal water loss, altered filaggrin degradation, and
decreased levels of SC free amino acids (Denecker et al.,
2008), all characteristics of AD-associated dry skin, it is
plausible that reduced amounts of this protease would be
involved in the pathogenesis of AD. These data confirm the
importance of filaggrin deficiency in AD and suggest that
shFLG-RHE is a good in vitro model of the epidermal defects
caused by the disease.
In conclusion, this study demonstrates that filaggrin defi-
ciency in RHE impairs the epidermal barrier function and
reproduces some of the alterations in the epidermal differ-
entiation program observed in AD patients.
MATERIALS AND METHODS
shRNA lentiviral particles
For filaggrin knockdown in keratinocytes, we used MISSION pLKO.
1-puro vector–based lentiviral particles containing a puromycin
resistance gene and a shRNA insert under the U6 promoter
(Sigma-Aldrich, St Louis, MO). Two shRNAs targeting filaggrin exon
3 (shFLG) were tested (shFLGa sequence: (nucleotide position
4934–4954 on the mRNA sequence, NCBI Reference Sequence:
NM_002016.1) 50-CCGGCCAGGTCCCATCAAGAAGATACTCGAGT
ATCTTCTTGATGGGACCTGGTTTTTG-30; shFLGb: (nucleotide posi-
tion 2078–2098) 50-CCGGGCACTCGTCACACACAGAATTCTCGAG
AATTCTGTGTGTGACGAGTGCTTTTTG-30). A nontarget shRNA that
does not target any known human gene (shc) was used as a control
(50-CCGGCAACAAGATGAAGAGCACCAACTC-30).
Keratinocyte culture and transduction
Primary normal human keratinocytes were obtained from abdominal
dermolipectomy of three different healthy subjects who had given
their informed consent. They were cultured in Complete DermaLife
medium (CellSystems, Troisdorf, Germany) in a humidified atmo-
sphere with 5% CO2. Keratinocytes were transduced with the
lentivirus containing either a shFLG or a nontarget shRNA control
at a multiplicity of infection of 10 in the presence of 4mg ml 1 of
protamine sulfate. After 24 hours of incubation, the culture medium
was replaced with fresh complete medium containing puromycin for
selection. When keratinocytes covered 60–70% of the flask area, they
were used to produce RHE on polycarbonate filters as described
previously (Frankart et al., 2012). More details are available in
Supplementary Materials and Methods online.
Immunostaining
On day 10, RHE samples were fixed with 4% formaldehyde-
containing buffer and paraffin-embedded. After deparaffinization
and hydration, sections were blocked with PBS containing 2%
BSA and incubated with primary antibodies (Supplementary Table
S1 online). After incubation with the corresponding secondary
antibody (Alexa Fluor 555 anti-rabbit IgG, Alexa Fluor 555 or 488
anti-mouse IgG, Alexa Fluor 555 or 488 anti-goat IgG, Invitrogen
Life Technologies, Carlsbad, CA), nuclei were stained with 40,60-
diamidino-2-phenylindole (DAPI; Sigma-Aldrich). The slides were
mounted with Mowiol 4–88 (Merck Millipore, Darmstadt, Germany)
and observed under a Nikon Eclipse 80i fluorescence microscope
equipped with a Nikon DXM 1200C digital camera and NIS image
analysis software (Nikon, Tokyo, Japan).
UV radiation
Control and filaggrin knockdown RHE samples were irradiated with
150 mJ cm
2
of UV-B (312 nm) using a crosslinker CL-508 (UVItec,
Chesterton, UK). Similar RHE samples were treated identically, except
for the exposure to UV light. After the treatment, the medium was
changed and RHE was further cultivated for 24 hours.
Western blotting
At day 10, RHE was lyzed in 100ml of Laemmli buffer and boiled
twice. Total epidermal proteins were separated on acrylamide gels,
and immunodetected with the primary antibodies listed in the
Supplementary Table S1 online and with peroxidase-conjugated
secondary antibodies (goat anti-rabbit IgG-horseradish peroxidase,
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SouthernBiotech, Birmingham, AL; goat anti-mouse IgG-horseradish
peroxidase, Bethyl Laboratories, Montgomery, TX). Reaction products
were detected by chemiluminescence with the ECL kit (Pierce/
Thermo Scientific, Rockford, IL). Quantity One 1-D Analysis Software
(Bio-Rad laboratories, Hercules, CA) was used to quantify immunor-
eactive bands on western blot films after scanning. Signals were
normalized to glyceraldehyde 3-phosphate dehydrogenase
immunodetection.
Quantitative real-time reverse-transcriptase–PCR
Reverse transcription was performed by using Improm-II Reverse-
Transcriptase (Promega, Madison,WI) with a combination of oligo(dT)
and random hexamers. Quantitative PCR amplification was per-
formed with the 7300 Real-Time PCR System (Applied Biosystems,
Foster City, CA) by using the Sybr quantitative PCR SuperMix W/ROX
(Invitrogen Life Technologies). The primers used are listed in the
Supplementary Table S2 online. Relative levels of gene expression
among samples were determined with the DD cycle threshold
method. TATA box-binding protein gene expression was used for
normalization.
Analysis of Lucifer yellow permeability
On day 10, 200ml of 1 m Lucifer yellow (Sigma-Aldrich) was added
onto the SC of the RHE. After incubation at 37 1C for 6 hours, the RHE
was fixed in 4% formaldehyde and embedded in paraffin. Sections
were inspected under the fluorescence microscope.
Determination of the urocanic acid and pyrrolidone carboxylic
acid contents
On day 10, RHE was lyzed in 0.1 M KOH and amino acids were
analyzed by HPLC as previously described (Kezic et al., 2009).
Patients and skin samples
Skin biopsies were collected from 15 patients with moderate-to-
severe AD (eight female and seven male patients; age 18–45 years;
median age 26.5 years) and 20 healthy volunteers (12 female and 8
male controls; age 18–49 years; median age 26.5 years) under
institutional review board-approved protocols, and written consent
was obtained, as reported previously (Pellerin et al., 2013). Patients
and controls were clinically characterized by an experienced
dermatologist. All patients underwent punch biopsies on their arms
(forearm, antecubital fossa, or wrist), on both lesional and non-
lesional skin sites as determined by careful examination of the skin.
Biopsies were obtained from controls without any history of atopy at
the corresponding skin site. Epidermal proteins were extracted as
described (Pellerin et al., 2013) and immunoblotted as described
above. FLG genotyping was performed in patients and controls for the
four FLG mutations most prevalent in the European population—
R501X, 2282del4, S3247X, and R2447X—using standard and already
published methods (Pellerin et al., 2013).
Statistical analysis
Statistical differences were determined with the Student t-test (SC
properties) and the Mann–Whitney test (caspase-14 activation and
amounts). A value of Po0.05 was considered statistically significant.
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